Back to Trades
Total Value
$158.5K
Net $158.5K sold
Filing Date
Jul 9, 2026
1 transaction
Sales
$158.5K
1 transaction
Trade Summary
On Jul 7, 2026, Borgeson Blake, Director, sold $158.5K of RECURSION PHARMACEUTICALS, INC. (RXRX) across 1 transaction. The filing covers Class A Common Stock and reflects net selling of $158.5K. Reported prices ranged from $3.96. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- RECURSION PHARMACEUTICALS, INC.
- Ticker Symbol
- RXRX
- CIK
- 0001601830
Insider Information
- Name
- Borgeson Blake
- Role
- Director
- Location
- SALT LAKE CITY, UT
Filing Details
- Filing Date
- Jul 9, 2026
- Transaction Date
- Jul 7, 2026
- Accession Number
- 0001856094-26-000011
- Form Type
- 4
- Net Trading Amount
- -$158.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 7, 2026 | Class A Common Stock | 40,000 | $3.96 | Sale | $158.5K |
Want live alerts when Borgeson Blake trades again?
Download Insider Trades to track RXRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.
- (F2)This transaction was executed in multiple trades at prices ranging from $3.95 to $4.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.